Factors modifying growth hormone estimates in immunoassays

Hormone Research in Paediatrics

Volumn 46, Issue 4-5, 1996, Pages 183-187

  Fisker, Sanne ^a   Ørskov, Hans ^b  

^a Medical Department M   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antibody; Growth hormone; Growth hormone binding protein; Immunometric assay; Radioimmunoassay

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; POLYCLONAL ANTIBODY;

ANALYTIC METHOD; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH DISORDER; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADULT; CARRIER PROTEINS; HUMAN GROWTH HORMONE; HUMANS; IMMUNOASSAY;

EID: 0029799105     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185020     Document Type: Article

References (35)

1. Baumann G: Growth hormone heterogeneity: Genes, isohormones, variants, and binding proteins, Endocr Rev 1991; 12:424-449.
2. Lewis UJ, Dunn JT, Bonewald LF, Scavev BK, Vandcrlaan WP: A naturally occurring structural variant ofhuman growth hormone, J Biol Chem 1978;253:2679-2687.
3. Baumann G, MacCart JG, Ambum K: The molecular nature of circulating growth hormone in normal and acromegalic man: Evidence for a principal and minor monomeric forms, J Clin Endocrinol Metab 1983:56:946-952.
4. Baumann G, Winter RJ, Shaw M: Circulating molecular variants of growth hormone in childhood, PediatrRes 1987;22:21-22.
5. Baumann G, Stolar MW: Molecular forms of human growth hormone secreted in vivo: Non-specificity of secretory stimuli, J Clin Endocrinol Metab 1986;62:789-790.
6. Stolar MW, Baumann G, Vance ML, Thomer MO: Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man, J Clin Endocrinol Metab 1984:59:235-239.
7. Stolar MW, Ambum K, Baumann G: Plasma 'big' and 'big-big' growth hormone (GH) in man: An oligomeric series composed of structurally diverse GH monomers, J Clin Endocrinol Metab 1984;59:212-218.
8. Baumann G, Stolar MW, Buchanan TA: Slow metabolic clearance rate of the 20.000-dalton variant of human growth hormone: Implications for biological activity, Endocrinology 1985:117:1309-1313.
9. Gorden P, Hendricks CM, Roth J: Evidence for 'big' and ‘little’ components of human plasma and pituitary growth hormone, J Clin Endocrinol Metab 1973;36:178-184.
10. Baumann G, Stolar MW, Ambum K: Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state, J Clin Endocrinol Metab 1985:60:1216-1220.
11. Reiter EO, Morris AH, MacGillivray MH, Weber D: Variable estimates of serum growth hormone concentrations by different radioassay systems, J Clin Endocrinol Metab 1988,66:68-71.
12. Orskov H, Wecke J, Fryslyk J, Kaal A, Nielsen S, Skjcerboek C, Christiansen JS, Möller N, Jorgensen JOL: Growth hormone determination in serum from patients with growth disorders: in Juul A, Jorgensen JOl, (eds): Growth Hormone in Adults: Physiological and Clinical Aspects, Cambridge, Cambridge University Press, 1996, pp 109-121.
13. Andersson AM, Orskov H, Ranke MB, Shalct S, Skakkcbtek NE: Interpretation of growth hormone provocative tests: Comparison of cutoff values in four European laboratories, Eur J Endocrinol 1995:132:340-343.
14. Levin PA, Chalew SA, Martin L, Kowarski AA: Comparison of assays for growth hormone using monoclonal or polyclonal antibodies for diagnosis of growth disorders, J Lab Clin Med 1987;109:85-88.
15. Cclnikcr AC, Chen AB, Wert RMJ, Sherman BM: Variability in the quantitation of circulating growth hormone using commercial immunoassays, J Clin Endocrinol Metab 1989:68: 469-476.
16. Orskov H, Thomsen HG, Yde H: Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone, Nature 1968:219:193-195.
17. Chatelain P, Bouillat B, Cohen R, Sassolas G, Souberbielle JC, Ruitton A, Jolv MO, Job JC: Assay of growth hormone levels in human plasma using commercial kits: Analysis of some factors influencing the results, Acta Paedialr Scand Suppl 1990:370:56-61.
18. Seth J, Hanning I, Bacon RR, Hunter WM: Quality of performance of assays for serum growth hormone in the United Kingdom (UK): Evidence from the UK external quality assessment scheme, 1980-1987, Clin Chem Acta 1988:174:171-183.
19. Bristow AF, Gaines Das R, JefTcoatc SL, Schulster D: The first international standard for somatotropin: Report of an international collaborative study, Growth Regul 1995:5: 133-141.
20. Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC: A specific growth hormone-binding protein in human plasma: Initial characterization, J Clin Endocrinol Metab 1986:62: 134-141.
21. Herington AC, Ymer S, Stevenson J: Identification and characterization of specific binding proteins for growth hormone in normal human sera, J Clin Invest 1986:77:1817-1823.
22. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood Wl: Growth hormone receptor and serum binding protein: Purification, cloning and expression, Nature 1987:330:537-543.
23. Mannor DA, Winer LM, Shaw MA, Baumann G: Plasma growth hormone (GH)-binding proteins: Effect on GH binding to receptors and GH action, J Clin Endocrinol Metab 1991:73: 30-34.
24. Hochberg Z, Bick T, Amit T: Stoichiometry of the pulsating growth hormone (GH) binding to the GH-binding protein and the turnover GH-rcceptor, Proc Soc Exp Biol Med 1994:206: 249-253.
25. Dattani MT, Hindmarsh PC, Brook CG, Robinson IC, Marshall NJ: Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system, J Endrocrinol 1994:140: 445-453.
26. Baumann G, Shaw MA: A second, lower affinity growth hormone-binding protein in human plasma, J Clin Endocrinol Metab 1990:70: 680-686.
27. Baumann G, Shaw MA: Plasma transport of the 20.000-dalton variant of human growth hormone (20K): Evidence for a 20K-specific binding site, J Clin Endocrinol Metab 1990:71: 1339-1343.
28. Jan T, Shaw MA, Baumann G: Effects of growth hormone-binding proteins on serum growth hormone measurements, J Clin Endocrinol Metab 1991;72:387-391.
29. Jorgersen JO, Pedersen SB, Borglum J, Frvstyk J, Ho KK, Christiansen JS, Orskov H, Blum WF, Richelsen B: Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: A doubleblind, placebo-controlled study, Eur J Endocrinol 1995;133:65-70.
30. Fiskcr S, Frystvk J, Skriver L, Vcstbo E, Ho KKY, Orskov H: A simple, rapid immunomet-ric assay for determination of functional and growth hormone (GH)-occupied GH-binding protein in human serum, Eur J Clin Invest, in press.
31. Nahm MH, Hoffmann JW: Heteroantibody: Phantom of the immunoassay, Clin Chem 1990:36:829.
32. Zwcig MH, Csako G, Benson CC, Weintraub BD, Kahn BB: Interference by anti-immuno-globulin G antibodies in immunoradiometric assays of thyrotropin involving mouse monoclonal antibodies, Clin Chem 1987:33:840-844.
33. Glick SM: Commentary on ‘The regulation of growth hormone secretion', Curr Contents 1979;20:250.
34. Glick SM, Roth J, Yalow RS, Berson SA: The regulation of growth hormone secretion, Rec Prog Horm Res 1965:21:241-283.
35. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK: Diagnosis of growth-hormone deficiency in adults, Lancet 1994:343:1064-1068.